SAFETY OF VEDOLIZUMAB, USTEKINUMAB AND TNF INHIBITORS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE MONOCENTRIC COHORT STUDY

Liesbeth Deroo  1     Laura Suarez  2     Marie Truyens  1, 1     Jeroen Geldof     Soumaya Akhayad     Goedele Dewitte     Elien Glorieus  1, 1     Triana Lobaton  1, 1    
1 Ghent University Hospital, Ghent, Belgium
2 University Hospital of Santiago of Compostela, Santiago de Compostela, Spain

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing